We also evaluated transcriptional levels of ARHGAP31, a Rho-GTPase activating protein, in DCs from GCD-CD patients (Figure 1E), showing a significant decrease in ARHGAP31 mRNA in GCD-CD compared with controls’ DCs (p < 0.01). This evidence concerns the gene STARD13 and Cowden disease.